Practice Area: 
Stock Symbol: 
Case Status: 

Ademi & O’Reilly, LLP is investigating Milacron Holdings Corp. (NYSE: MCRN) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Milacron to Hillenbrand.

Ademi & O’Reilly, LLP alleges Milacron’s financial outlook is improving and yet shareholders will receive only the equivalent of $18.07 per share for each share of Milacron common stock they own.  Hillenbrand is acquiring Milacron at a substantial discount.  The merger agreement unreasonably limits competing bids for Milacron by prohibiting solicitation of further bids, and imposing a termination penalty if Milacron accepts a superior bid. Milacron insiders will receive millions of dollars as part of change of control arrangements. We are investigating on the conduct of Milacron’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Milacron.